Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Presti

Showing results (71-80 of 99) with videos related to

Pageof 10
Sort By:
The Journal of Experimental Medicine|June 27, 2024
Maturation of germinal center B cells after influenza virus vaccination in humansKatherine M McIntire, Hailong Meng, Ting-Hui Lin, et al.
Annals of Internal Medicine|October 7, 2014
Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trialJeffrey L Lennox, Raphael J Landovitz, Heather J Ribaudo, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2021
A public vaccine-induced human antibody protects against SARS-CoV-2 and emerging variantsAaron J Schmitz, Jackson S Turner, Zhuoming Liu, et al.
Nature Immunology|June 15, 2026
mRNA-based influenza vaccine expands the B cell response breadth in humansHanover C Matz, Tae-Geun Yu, Kritika Dixit, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2021
Increased complement activation is a distinctive feature of severe SARS-CoV-2 infectionLina Ma, Sanjaya K Sahu, Marlene Cano, et al.
JCI Insight|January 4, 2024
Immunoglobulin replacement products protect against SARS-CoV-2 infection in vivo despite poor neutralizing activityOfer Zimmerman, Alexa Michelle Altman Doss, Baoling Ying, et al.
Cell|January 13, 2022
SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humansPhilip A Mudd, Anastasia A Minervina, Mikhail V Pogorelyy, et al.
Science Immunology|October 10, 2025
Germinal center-mediated broadening of B cell responses to SARS-CoV-2 booster immunizationSameer Kumar Malladi, Deepika Jaiswal, Baoling Ying, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2024
Defining a highly conserved B cell epitope in the receptor binding motif of SARS-CoV-2 spike glycoproteinSameer Kumar Malladi, Deepika Jaiswal, Baoling Ying, et al.
Cell Reports. Medicine|June 10, 2022
mRNA vaccine boosting enhances antibody responses against SARS-CoV-2 Omicron variant in individuals with antibody deficiency syndromesOfer Zimmerman, Alexa Michelle Altman Doss, Paulina Kaplonek, et al.
Pageof 10

Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
The Journal of Experimental Medicine|June 27, 2024
Maturation of germinal center B cells after influenza virus vaccination in humansKatherine M McIntire, Hailong Meng, Ting-Hui Lin, et al.
Annals of Internal Medicine|October 7, 2014
Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trialJeffrey L Lennox, Raphael J Landovitz, Heather J Ribaudo, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2021
A public vaccine-induced human antibody protects against SARS-CoV-2 and emerging variantsAaron J Schmitz, Jackson S Turner, Zhuoming Liu, et al.
Nature Immunology|June 15, 2026
mRNA-based influenza vaccine expands the B cell response breadth in humansHanover C Matz, Tae-Geun Yu, Kritika Dixit, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2021
Increased complement activation is a distinctive feature of severe SARS-CoV-2 infectionLina Ma, Sanjaya K Sahu, Marlene Cano, et al.
JCI Insight|January 4, 2024
Immunoglobulin replacement products protect against SARS-CoV-2 infection in vivo despite poor neutralizing activityOfer Zimmerman, Alexa Michelle Altman Doss, Baoling Ying, et al.
Cell|January 13, 2022
SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humansPhilip A Mudd, Anastasia A Minervina, Mikhail V Pogorelyy, et al.
Science Immunology|October 10, 2025
Germinal center-mediated broadening of B cell responses to SARS-CoV-2 booster immunizationSameer Kumar Malladi, Deepika Jaiswal, Baoling Ying, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2024
Defining a highly conserved B cell epitope in the receptor binding motif of SARS-CoV-2 spike glycoproteinSameer Kumar Malladi, Deepika Jaiswal, Baoling Ying, et al.
Cell Reports. Medicine|June 10, 2022
mRNA vaccine boosting enhances antibody responses against SARS-CoV-2 Omicron variant in individuals with antibody deficiency syndromesOfer Zimmerman, Alexa Michelle Altman Doss, Paulina Kaplonek, et al.
Pageof 10